Recently a major FDA official Peter Marks announced his resignation, heavily impacting biotech stocks such as Moderna. Wall Street is currently stressing about the future of biopharmaceutical companies and the industry as a whole. Moderna Stock Falls Marks played a significant ro
Moderna is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of cardiovascular and autoimmune diseases.